Eli Lilly and Company reports positive Phase 3 LIBRETTO-432 results for Retevmo in early-stage RET fusion-positive NSCLC

Beyfortus study shows sustained reduction in infant RSV hospitalisations across two seasons

Coreline Soft collaborates with INFINITT North America to provide AI workflow for US radiology practices

AstraZeneca reports positive Phase III results for BREZTRI in uncontrolled asthma

Akeso's AK139 Phase II clinical trials approved in China

Median Technologies secures FDA clearance for AI lung cancer screening software

Insilico Medicine names new vice president, Clinical Development – Oncology

Partner Therapeutics' zenocutuzumab-zbco granted US FDA Orphan Drug Designation for treatment of cholangiocarcinoma

Cizzle Biotechnology secures Canadian patent for lung cancer biomarker test

DATROWAY receives US priority review for first-line metastatic triple negative breast cancer

Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA

Guerbet's contrast agent Elucirem approved by European Commission in children from birth

United Therapeutics reports positive phase 1 data for bioengineered liver in acute liver failure

European Commission approves GSK's Arexvy for adults aged 18 and over

Roivant to announce Q3 2026 financial results